ASI-MV Solutions: A Tailored Program for Substance Abusers in Early Recovery
2013年9月20日 更新者:Emil Chiauzzi、Inflexxion, Inc.
Making referrals to medical and psychosocial services for substance abuse clients has proven difficult due to lack of access to services, inadequate counselor knowledge, and lack of motivation and skills among clients.
Inflexxion is proposing the development of ASI-MV Solutions, which will educate clients about employment, legal, psychiatric, relapse prevention, medical, and family issues, as well as include resources and strategies for counselors.
By linking learning modules to client results on the ASI-MV, an online interactive version of the ASI administered in treatment settings, we will be able to offer clients important tools to address key recovery issues and encourage counselors to make appropriate referrals to medical and psychosocial services.
研究概览
详细说明
Substance abuse research indicates that: (1) addressing medical and psychosocial problems associated with substance abuse and dependence leads to better outcomes; (2) treatments are now shorter due in part to rising healthcare costs, and it is difficult to address these issues effectively during treatment, making medical and psychosocial ("wraparound") services following treatment essential; (3) counselors may lack the knowledge to effectively integrate these services; and (4) referrals to these services have been underutilized and clients may lack the motivation, knowledge, or skills to follow up with the referrals when they are made.
To address these deficits, we are proposing the development of ASI-MV Solutions, which will provide tailored motivational feedback and skill-building lessons to clients to address specific psychosocial and medical problem areas.
We expect that ASI-MV Solutions will have seven modules (Alcohol, Drugs, Medical, Psychiatric, Legal, Employment, and Family) corresponding to domains of the ASI-MV, a Web-enabled interactive version of the ASI administered in treatment settings.
Substance abusers who have high severity scores on ASI-MV subscales will be directed to corresponding interactive lessons and local resources on ASI-MV Solutions.
To demonstrate the feasibility of the program concept, the Phase I study focused on the Employment domain.
All feasibility criteria were met and findings indicated: (1) Proposed content was based on highly positive findings from concept mapping, as well as usability and acceptance testing with clients and experts.
Ratings of potential effectiveness and appeal were high.
(2) Usability testing indicated that the program was usable by the target audience, the skills and outcomes were relevant to the target audience, and the program was regarded as potentially very helpful to the treatment process.
We surpassed feasibility benchmarks for both clients and experts.
(3) Our technical/design team produced a demonstration program that was perceived by key stakeholders as highly usable and engaging multimedia program, as well as determining the necessary technologies to produce the complete program in Phase II.
In Phase II we will develop ASI-MV Solutions content, complete the ASI-MV Solutions program, field test the program, and conduct satisfaction and acceptance testing of the program with clients and counselors.
研究类型
介入性
注册 (实际的)
39
阶段
- 阶段2
参与标准
研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
- 孩子
- 成人
- 年长者
接受健康志愿者
不
有资格学习的性别
全部
描述
Inclusion Criteria:
- Client Inclusion Criteria. We will recruit participants in the same proportions as in usability testing - 40% female, 40% minorities. The inclusion criteria for clients are the same as those for usability testing, except that we will require the participant to provide: (1) the names of at least three contacts who can help locate the client during the study, and (2) multiple means of contacting them (telephone, mail, and/or email). As with usability participants, we will seek clients who are in the early stages of treatment (30 days or less, including new intakes).
Exclusion Criteria:
- None
学习计划
本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。
研究是如何设计的?
设计细节
- 主要用途:预防
- 分配:非随机化
- 介入模型:并行分配
- 屏蔽:双倍的
武器和干预
参与者组/臂 |
干预/治疗 |
---|---|
实验性的:ASI-MV Solutions
The Experimental group will complete the ASI-MV and use the ASI-MV Solutions program for eight 30-minute sessions, followed by monthly booster sessions.
The Experimental group will undergo a baseline assessment and one-month post-baseline, two-month post-baseline, and six-month post-intervention.
|
The Experimental group will complete the ASI-MV and use the ASI-MV Solutions program for eight 30-minute sessions, followed by monthly booster sessions.
The Experimental group will undergo a baseline assessment and one-month post-baseline, two-month post-baseline, and six-month post-intervention.
|
无干预:Treatment as Usual
The Control group participants will complete the ASI-MV and receive their normal course of treatment.
The Control group will undergo a baseline assessment and one-month post-baseline, two-month post-baseline, and six-month post-intervention.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
---|---|---|
improved outcomes, as measured by substance use, psychosocial, and psychological functioning
大体时间:baseline assessment and one-month post-baseline, two-month post-baseline, and six-month post-intervention
|
Addiction Severity Index - Multimedia Version (ASI-MV)
|
baseline assessment and one-month post-baseline, two-month post-baseline, and six-month post-intervention
|
greater problem-services matching, as measured by the number and fit of referred/received services
大体时间:baseline assessment and one-month post-baseline, two-month post-baseline, and six-month post-intervention
|
Treatment Services Checklist (Client Version) and Treatment Services Checklist (Counselor Version).
|
baseline assessment and one-month post-baseline, two-month post-baseline, and six-month post-intervention
|
greater treatment motivation
大体时间:baseline assessment and one-month post-baseline, two-month post-baseline, and six-month post-intervention
|
Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES, Version 8D; Miller & Tonigan, 1996)
|
baseline assessment and one-month post-baseline, two-month post-baseline, and six-month post-intervention
|
greater self-efficacy in managing psychosocial issues
大体时间:baseline assessment and one-month post-baseline, two-month post-baseline, and six-month post-intervention
|
Drug Avoidance Self-Efficacy Scale
|
baseline assessment and one-month post-baseline, two-month post-baseline, and six-month post-intervention
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
---|---|---|
treatment compliance
大体时间:baseline assessment and one-month post-baseline, two-month post-baseline, and six-month post-intervention
|
Treatment Compliance: We will ask counselors to record scheduled and planned sessions within the treatment facility as a way of assessing treatment compliance.
We will also ask counselors to record client reasons for leaving treatment prematurely (Against Medical Advice, moving, hospitalization, etc.).
|
baseline assessment and one-month post-baseline, two-month post-baseline, and six-month post-intervention
|
treatment alliance with counselors
大体时间:baseline assessment and one-month post-baseline, two-month post-baseline, and six-month post-intervention
|
Working Alliance Inventory-Short Form (Clients) and Working Alliance Inventory-Short Form (Counselors)
|
baseline assessment and one-month post-baseline, two-month post-baseline, and six-month post-intervention
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
调查人员
- 首席研究员:Emil Chiauzzi, PhD、Inflexxion, Inc.
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始
2010年7月1日
初级完成 (实际的)
2013年7月1日
研究完成 (实际的)
2013年7月1日
研究注册日期
首次提交
2010年7月27日
首先提交符合 QC 标准的
2013年9月20日
首次发布 (估计)
2013年9月23日
研究记录更新
最后更新发布 (估计)
2013年9月23日
上次提交的符合 QC 标准的更新
2013年9月20日
最后验证
2013年9月1日
更多信息
与本研究相关的术语
其他研究编号
- 2R44DA026232-02 (美国 NIH 拨款/合同)
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.
ASI-MV Solutions的临床试验
-
University of ManitobaSt. Boniface Hospital; Arterial Stiffness Incorporated终止
-
Royal Marsden NHS Foundation TrustImperial College London; Institute of Cancer Research, United Kingdom; RM Partners West London...招聘中
-
Teva Neuroscience, Inc.完全的
-
Bandim Health ProjectAarhus University Hospital; Rigshospitalet, Denmark完全的
-
Rutgers, The State University of New Jersey招聘中
-
Themis Bioscience GmbHWalter Reed Army Institute of Research (WRAIR)完全的